Indiana Biosciences Research Institute selects CDD Vault to manage experimental data for translational research

CDD Vault at the IBRI available to its members, collaborators

Indianapolis, Ind. - The Indiana Biosciences Research Institute (IBRI), a leading translational science institute, today announced an agreement with Collaborative Drug Discovery, Inc. (CDD) that will help it translate disease hypotheses into potential therapies that improve patient health outcomes.

The IBRI will add CDD Vault®, a hosted software that provides a secure, central storage for chemical and biological data, to its drug discovery resources. “CDD Vault is the clear industry standard at private companies and within the university setting,” said Alan Palkowitz, PhD, president and CEO of the IBRI. “As an institute that prides itself in bringing stakeholders together, this collaboration solidifies our role as a key strategic partner with industry and academic centers to find innovative solutions to some of the most challenging biomedical problems.”

CDD Vault is one of many technologies the IBRI is accessing to expand its capabilities for molecular innovation. What makes the IBRI’s agreement with CDD unique is that the IBRI will be able to use CDD Vault within its research labs and to also share with external collaborators.

“We are thrilled to work with the IBRI as its scientists translate their findings into novel patient therapies,” said Barry Bunin, PhD, CEO of CDD. “IBRI includes a number of leading researchers from the Big Pharma world.  This collaboration will help the IBRI enhance its chemical infrastructure, improve tracking of its drug discovery progress and enable innovation in the life sciences ecosystem.”

About the Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery science and applied research institute currently targeting diabetes, metabolic disease, poor nutrition and related health data science.  Inspired by Indiana’s leading life sciences companies, research universities and philanthropic community, the IBRI is building a world-class organization of researchers, innovators and entrepreneurs to catalyze scientific discovery and its applications, resulting in improved health outcomes for Indiana patients and beyond. For more information about the IBRI, visit https://www.indianabiosciences.org/.

About Collaborative Drug Discovery, Inc.

CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®,” is used to manage chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault® is a hosted database solution for secure management and sharing of biological and chemical data. It lets you intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. Available modules within CDD Vault include Activity & Registration, Visualization, Inventory, and ELN. A complete list of more than 60 publications and patents from CDD can be found online on our resources page at https://www.collaborativedrug.com/publications-and-resources/.